Cellectar Biosciences Income Statement (2009-2014) | CLRB

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014
Revenue & cost
Revenue 0.03M0.03M0.01M-0.01M0.01M0.01M0.01M0.17M0.04M0.24M0.24M0.24M
Operating items
Research & Development 1.78M1.59M1.77M2.94M1.91M0.20M0.37M0.50M0.47M0.96M1.01M20.81M1.33M1.31M1.25M25.93M1.59M1.65M2.07M32.79M1.72M
Selling, General & Administrative 0.48M0.51M0.55M0.65M0.64M0.74M0.54M-0.77M0.13M0.80M0.91M9.66M1.00M0.90M0.80M13.29M1.12M1.07M0.84M17.74M1.09M
Other Operating Expenses 0.05M0.25M0.50M0.80M0.80M1.90M0.02M
Operating Expenses 2.26M2.10M2.31M3.60M2.56M0.94M0.92M-0.22M0.85M2.25M1.91M31.27M2.33M2.21M2.05M40.02M2.71M2.72M2.91M52.42M2.82M
Operating Income -2.23M-2.06M-2.30M-3.64M-2.55M-0.93M-0.91M0.19M-0.85M-2.25M-1.91M-31.27M-2.33M-2.21M-2.05M-40.02M-2.71M-2.72M-2.91M-52.42M-2.82M
EBIT -2.23M-2.06M-2.30M-3.64M-2.55M-0.93M-0.91M0.19M-0.85M-2.25M-1.91M-31.27M-2.33M-2.21M-2.05M-40.02M-2.71M-2.72M-2.91M-52.42M-2.82M
Non-operating items
Non Operating Investment Income 0.41M-2.80M-0.45M0.00M-0.00M
Interest & Investment Income 0.00M-1.001.000.00M-0.57M-0.16M-0.27M-0.00M-0.45M-0.00M-0.00M-0.00M-0.46M-0.00M-0.00M-0.00M-0.46M-0.07M
Other Non Operating Income 0.00M0.00M0.00M-0.50M-0.32M0.82M-0.07M0.00M-0.01M-0.03M-0.02M0.00M-0.05M-0.74M0.66M1.60M2.33M-0.05M
Non Operating Income 0.42M-2.79M-0.45M-9.22M7.90M-0.50M-0.32M-7.45M-0.11M-0.34M0.00M-0.21M-0.03M-0.02M0.00M-0.26M-0.74M0.66M1.60M1.36M-0.12M
Net income details
EBT -2.23M-2.06M-2.30M-3.64M-2.55M-0.93M-0.91M-0.37M-1.01M-2.52M-1.91M-31.71M-2.33M-2.21M-2.06M-40.48M-2.71M-2.72M-2.91M-52.89M-2.89M
Profit After Tax -1.81M-4.86M-2.74M-12.86M5.35M-1.43M-1.23M-7.25M-0.97M-2.60M-1.91M-31.48M-2.36M-2.23M-2.05M-40.28M-3.45M-2.06M-1.32M-51.06M-2.94M
Income from Continuing Operations -2.23M-2.06M-2.30M-3.64M-2.55M-0.93M-0.91M-0.37M-1.01M-2.52M-1.91M-31.71M-2.33M-2.21M-2.06M-40.48M-2.71M-2.72M-2.91M-52.89M-2.89M
Consolidated Net Income -2.23M-2.06M-2.30M-3.64M-2.55M-0.93M-0.91M-0.37M-1.01M-2.52M-1.91M-31.71M-2.33M-2.21M-2.06M-40.48M-2.71M-2.72M-2.91M-52.89M-2.89M
Income towards Parent Company -2.23M-2.06M-2.30M-3.64M-2.55M-0.93M-0.91M-0.37M-1.01M-2.52M-1.91M-31.71M-2.33M-2.21M-2.06M-40.48M-2.71M-2.72M-2.91M-52.89M-2.89M
Preferred Dividend Payments -0.77M-0.88M-0.84M-0.80M-0.66M-0.58M-0.58M-0.39M
Net Income towards Common Stockholders 3.30M-5.74M3.59M13.66M4.69M2.01M-2.39M-12.94M-1.01M-2.52M-1.91M-1.97M-2.36M-2.23M-2.60M-40.82M-3.45M-2.06M-1.32M-51.60M-2.94M
Additional items
EPS (Basic) 0.070.13-0.070.278.990.16-0.19-1.01-0.08-0.10-0.07-0.08-0.06-0.06-0.06-0.99-0.07-0.72-0.46-18.47-1.03
Shares Outstanding (Weighted Average) 43.98M44.14M49.65M49.91M12.82M12.82M12.82M12.82M25.74M26.83M23.96M36.91M38.60M43.29M41.12M51.29M2.87M2.87M2.79M2.87M2.87M5.01M
EBITDA -2.23M-2.06M-2.30M-3.64M-2.55M-0.93M-0.91M0.19M-0.85M-2.25M-1.91M-31.27M-2.33M-2.21M-2.05M-40.02M-2.71M-2.72M-2.91M-52.42M-2.82M
Shares Outstanding 12.82M12.82M36.91M2.32M0.29M